CN108690724A - A kind of application of ford dutchmanspipe root or herb volatile oil in preparing anti-curing cancers and/antibacterial product - Google Patents
A kind of application of ford dutchmanspipe root or herb volatile oil in preparing anti-curing cancers and/antibacterial product Download PDFInfo
- Publication number
- CN108690724A CN108690724A CN201810449997.7A CN201810449997A CN108690724A CN 108690724 A CN108690724 A CN 108690724A CN 201810449997 A CN201810449997 A CN 201810449997A CN 108690724 A CN108690724 A CN 108690724A
- Authority
- CN
- China
- Prior art keywords
- volatile oil
- herb
- dutchmanspipe root
- ford dutchmanspipe
- ford
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000341 volatile oil Substances 0.000 title claims abstract description 146
- 230000000844 anti-bacterial effect Effects 0.000 title claims abstract description 19
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 46
- 238000000605 extraction Methods 0.000 claims abstract description 38
- 238000001256 steam distillation Methods 0.000 claims abstract description 20
- 239000003960 organic solvent Substances 0.000 claims abstract description 17
- 230000018044 dehydration Effects 0.000 claims abstract description 16
- 238000006297 dehydration reaction Methods 0.000 claims abstract description 16
- 230000001093 anti-cancer Effects 0.000 claims abstract description 10
- 239000002274 desiccant Substances 0.000 claims abstract description 8
- 238000001035 drying Methods 0.000 claims abstract description 8
- 238000001914 filtration Methods 0.000 claims abstract description 8
- 238000003756 stirring Methods 0.000 claims abstract description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 40
- 150000001336 alkenes Chemical class 0.000 claims description 31
- 241000894006 Bacteria Species 0.000 claims description 23
- WLNGPDPILFYWKF-OAHLLOKOSA-N (-)-beta-chamigrene Chemical compound C1CC(C)=CC[C@]21C(C)(C)CCCC2=C WLNGPDPILFYWKF-OAHLLOKOSA-N 0.000 claims description 16
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 claims description 16
- -1 trans- -2- menthols Chemical compound 0.000 claims description 15
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 claims description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 12
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 11
- 239000000126 substance Substances 0.000 claims description 11
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 9
- 241000588724 Escherichia coli Species 0.000 claims description 9
- 241000191967 Staphylococcus aureus Species 0.000 claims description 9
- XUEHVOLRMXNRKQ-KHMAMNHCSA-N alpha-cubebene Chemical compound CC(C)[C@@H]([C@H]12)CC[C@@H](C)[C@]32[C@@H]1C(C)=CC3 XUEHVOLRMXNRKQ-KHMAMNHCSA-N 0.000 claims description 9
- VPDZRSSKICPUEY-GQRSATBHSA-N (+)-Bicyclogermacrene Natural products CC1(C)[C@@H]/2[C@H]1CC/C(/C)=C\CC/C(/C)=C\2 VPDZRSSKICPUEY-GQRSATBHSA-N 0.000 claims description 8
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 claims description 8
- JSNRRGGBADWTMC-UHFFFAOYSA-N (6E)-7,11-dimethyl-3-methylene-1,6,10-dodecatriene Chemical compound CC(C)=CCCC(C)=CCCC(=C)C=C JSNRRGGBADWTMC-UHFFFAOYSA-N 0.000 claims description 8
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 claims description 8
- 206010006187 Breast cancer Diseases 0.000 claims description 8
- 208000026310 Breast neoplasm Diseases 0.000 claims description 8
- 240000006122 Chenopodium album Species 0.000 claims description 8
- 235000009344 Chenopodium album Nutrition 0.000 claims description 8
- MOYAFQVGZZPNRA-UHFFFAOYSA-N Terpinolene Chemical compound CC(C)=C1CCC(C)=CC1 MOYAFQVGZZPNRA-UHFFFAOYSA-N 0.000 claims description 8
- VPDZRSSKICPUEY-JEPMYXAXSA-N bicyclogermacrene Chemical compound C1CC(/C)=C/CC\C(C)=C\[C@@H]2C(C)(C)[C@H]12 VPDZRSSKICPUEY-JEPMYXAXSA-N 0.000 claims description 8
- RXARZHLXLNWPFG-UHFFFAOYSA-N bicyclogermacrene Natural products CC1=C2C3C(CCC2=CCC1)C3(C)C RXARZHLXLNWPFG-UHFFFAOYSA-N 0.000 claims description 8
- YOCDGWMCBBMMGJ-UHFFFAOYSA-N delta-cadinene Natural products C1C=C(C)CC2C(C(C)C)CCC(=C)C21 YOCDGWMCBBMMGJ-UHFFFAOYSA-N 0.000 claims description 8
- MXDMETWAEGIFOE-CABCVRRESA-N delta-elemene Chemical compound CC(C)C1=C[C@H](C(C)=C)[C@@](C)(C=C)CC1 MXDMETWAEGIFOE-CABCVRRESA-N 0.000 claims description 8
- 239000004744 fabric Substances 0.000 claims description 8
- 229930007744 linalool Natural products 0.000 claims description 8
- LHYHMMRYTDARSZ-YJNKXOJESA-N t-cadinol Natural products C1CC(C)=C[C@@H]2[C@H](C(C)C)CC[C@](C)(O)[C@@H]21 LHYHMMRYTDARSZ-YJNKXOJESA-N 0.000 claims description 8
- YKFLAYDHMOASIY-UHFFFAOYSA-N γ-terpinene Chemical compound CC(C)C1=CCC(C)=CC1 YKFLAYDHMOASIY-UHFFFAOYSA-N 0.000 claims description 8
- CKZXONNJVHXSQM-UHFFFAOYSA-N Ledol Natural products CC(C)C1CCC(C)(O)C2C3CC(C)CC123 CKZXONNJVHXSQM-UHFFFAOYSA-N 0.000 claims description 7
- PDSNLYSELAIEBU-UHFFFAOYSA-N Longifolene Chemical compound C1CCC(C)(C)C2C3CCC2C1(C)C3=C PDSNLYSELAIEBU-UHFFFAOYSA-N 0.000 claims description 7
- ZPUKHRHPJKNORC-UHFFFAOYSA-N Longifolene Natural products CC1(C)CCCC2(C)C3CCC1(C3)C2=C ZPUKHRHPJKNORC-UHFFFAOYSA-N 0.000 claims description 7
- 241000589517 Pseudomonas aeruginosa Species 0.000 claims description 7
- QMAYBMKBYCGXDH-UHFFFAOYSA-N alpha-amorphene Natural products C1CC(C)=CC2C(C(C)C)CC=C(C)C21 QMAYBMKBYCGXDH-UHFFFAOYSA-N 0.000 claims description 7
- 239000003795 chemical substances by application Substances 0.000 claims description 7
- 239000000470 constituent Substances 0.000 claims description 7
- 229940087305 limonene Drugs 0.000 claims description 7
- 235000001510 limonene Nutrition 0.000 claims description 7
- 239000001161 piper cubeba l. fruit oil Substances 0.000 claims description 7
- OPFTUNCRGUEPRZ-UHFFFAOYSA-N (+)-beta-Elemen Natural products CC(=C)C1CCC(C)(C=C)C(C(C)=C)C1 OPFTUNCRGUEPRZ-UHFFFAOYSA-N 0.000 claims description 6
- LDWAIHWGMRVEFR-UHFFFAOYSA-N (6,6-dimethyl-4-bicyclo[3.1.1]heptanyl)methanol Chemical compound C1C2C(C)(C)C1CCC2CO LDWAIHWGMRVEFR-UHFFFAOYSA-N 0.000 claims description 6
- BXGVVQADPFXGHD-LSDHHAIUSA-N (7s,9as)-4,4,7,9a-tetramethyl-1,2,3,6,8,9-hexahydrobenzo[7]annulen-7-ol Chemical compound C1C[C@](C)(O)CC=C2C(C)(C)CCC[C@]21C BXGVVQADPFXGHD-LSDHHAIUSA-N 0.000 claims description 6
- 201000007270 liver cancer Diseases 0.000 claims description 6
- 208000014018 liver neoplasm Diseases 0.000 claims description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 6
- 235000004692 Eucalyptus globulus Nutrition 0.000 claims description 5
- 235000019134 Eucalyptus tereticornis Nutrition 0.000 claims description 5
- 201000011510 cancer Diseases 0.000 claims description 5
- 239000008194 pharmaceutical composition Substances 0.000 claims description 5
- WRHGORWNJGOVQY-KKUMJFAQSA-N (+)-gamma-cadinene Chemical compound C1CC(C)=C[C@H]2[C@H](C(C)C)CCC(=C)[C@@H]21 WRHGORWNJGOVQY-KKUMJFAQSA-N 0.000 claims description 4
- FUCYIEXQVQJBKY-ZFWWWQNUSA-N (+)-δ-Cadinene Chemical compound C1CC(C)=C[C@H]2[C@H](C(C)C)CCC(C)=C21 FUCYIEXQVQJBKY-ZFWWWQNUSA-N 0.000 claims description 4
- LHYHMMRYTDARSZ-GBJTYRQASA-N (-)-alpha-Cadinol Natural products C1CC(C)=C[C@@H]2[C@H](C(C)C)CC[C@@](C)(O)[C@@H]21 LHYHMMRYTDARSZ-GBJTYRQASA-N 0.000 claims description 4
- SPCXZDDGSGTVAW-XIDUGBJDSA-N (-)-alpha-gurjunene Chemical compound C[C@@H]1CC[C@H]2C(C)(C)[C@H]2C2=C(C)CC[C@H]12 SPCXZDDGSGTVAW-XIDUGBJDSA-N 0.000 claims description 4
- OPFTUNCRGUEPRZ-QLFBSQMISA-N (-)-beta-elemene Chemical compound CC(=C)[C@@H]1CC[C@@](C)(C=C)[C@H](C(C)=C)C1 OPFTUNCRGUEPRZ-QLFBSQMISA-N 0.000 claims description 4
- DPQYOKVMVCQHMY-QPSCCSFWSA-N (1s,4as,7r,8as)-1,4a-dimethyl-7-prop-1-en-2-yl-2,3,4,5,6,7,8,8a-octahydronaphthalen-1-ol Chemical compound C1CC[C@](C)(O)[C@H]2C[C@H](C(=C)C)CC[C@@]21C DPQYOKVMVCQHMY-QPSCCSFWSA-N 0.000 claims description 4
- GQVMHMFBVWSSPF-SOYUKNQTSA-N (4E,6E)-2,6-dimethylocta-2,4,6-triene Chemical compound C\C=C(/C)\C=C\C=C(C)C GQVMHMFBVWSSPF-SOYUKNQTSA-N 0.000 claims description 4
- JSNRRGGBADWTMC-QINSGFPZSA-N (E)-beta-Farnesene Natural products CC(C)=CCC\C(C)=C/CCC(=C)C=C JSNRRGGBADWTMC-QINSGFPZSA-N 0.000 claims description 4
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 claims description 4
- GOQRXDTWKVYHJH-UHFFFAOYSA-N 1-methylidene-4-prop-1-en-2-ylcyclohexane Chemical compound CC(=C)C1CCC(=C)CC1 GOQRXDTWKVYHJH-UHFFFAOYSA-N 0.000 claims description 4
- 241000744007 Andropogon Species 0.000 claims description 4
- 241000723346 Cinnamomum camphora Species 0.000 claims description 4
- 239000004593 Epoxy Substances 0.000 claims description 4
- TWVJWDMOZJXUID-SDDRHHMPSA-N Guaiol Chemical compound C1([C@H](CC[C@H](C2)C(C)(C)O)C)=C2[C@@H](C)CC1 TWVJWDMOZJXUID-SDDRHHMPSA-N 0.000 claims description 4
- DPQYOKVMVCQHMY-ZQDZILKHSA-N Isointermedeol Natural products O[C@@]1(C)[C@@H]2[C@](C)(CC[C@H](C(=C)C)C2)CCC1 DPQYOKVMVCQHMY-ZQDZILKHSA-N 0.000 claims description 4
- TUWWTQRJWLLWJE-UHFFFAOYSA-N Viridiflorol Natural products CC1CCC2C1C3C(CCC2(O)O)C3(C)C TUWWTQRJWLLWJE-UHFFFAOYSA-N 0.000 claims description 4
- SHOKWSLXDAIZPP-UHFFFAOYSA-N [4-(4-iodooxy-2-methyl-5-propan-2-ylphenyl)-5-methyl-2-propan-2-ylphenyl] hypoiodite Chemical compound C1=C(OI)C(C(C)C)=CC(C=2C(=CC(OI)=C(C(C)C)C=2)C)=C1C SHOKWSLXDAIZPP-UHFFFAOYSA-N 0.000 claims description 4
- LHYHMMRYTDARSZ-BYNSBNAKSA-N alpha-cadinol Chemical compound C1CC(C)=C[C@H]2[C@H](C(C)C)CC[C@@](C)(O)[C@@H]21 LHYHMMRYTDARSZ-BYNSBNAKSA-N 0.000 claims description 4
- DMVUUDMWVRKRFV-UHFFFAOYSA-N alpha-cadinol Natural products CC(O)C1CCC(C)(C)C2CCC(=CC12)C DMVUUDMWVRKRFV-UHFFFAOYSA-N 0.000 claims description 4
- FJNHFUOCVLERHW-UHFFFAOYSA-N alpha-gurjunene Natural products CC1CCC2C(C3=CCCC13)C2(C)C FJNHFUOCVLERHW-UHFFFAOYSA-N 0.000 claims description 4
- CSKINCSXMLCMAR-RWSFTLGLSA-N beta-Patchoulene Natural products C[C@H]1CCC=2[C@@]3(CC[C@H](CC1=2)C3(C)C)C CSKINCSXMLCMAR-RWSFTLGLSA-N 0.000 claims description 4
- YSNRTFFURISHOU-UHFFFAOYSA-N beta-farnesene Natural products C=CC(C)CCC=C(C)CCC=C(C)C YSNRTFFURISHOU-UHFFFAOYSA-N 0.000 claims description 4
- 125000002619 bicyclic group Chemical group 0.000 claims description 4
- 229930008380 camphor Natural products 0.000 claims description 4
- 229960000846 camphor Drugs 0.000 claims description 4
- SVURIXNDRWRAFU-OGMFBOKVSA-N cedrol Chemical compound C1[C@]23[C@H](C)CC[C@H]3C(C)(C)[C@@H]1[C@@](O)(C)CC2 SVURIXNDRWRAFU-OGMFBOKVSA-N 0.000 claims description 4
- 229940026455 cedrol Drugs 0.000 claims description 4
- PCROEXHGMUJCDB-UHFFFAOYSA-N cedrol Natural products CC1CCC2C(C)(C)C3CC(C)(O)CC12C3 PCROEXHGMUJCDB-UHFFFAOYSA-N 0.000 claims description 4
- GQVMHMFBVWSSPF-UHFFFAOYSA-N cis-alloocimene Natural products CC=C(C)C=CC=C(C)C GQVMHMFBVWSSPF-UHFFFAOYSA-N 0.000 claims description 4
- 150000001993 dienes Chemical class 0.000 claims description 4
- WGTRJVCFDUCKCM-UHFFFAOYSA-N ent-ledene Natural products C1CC2C(C)(C)C2C2C(C)CCC2=C1C WGTRJVCFDUCKCM-UHFFFAOYSA-N 0.000 claims description 4
- 230000001408 fungistatic effect Effects 0.000 claims description 4
- JBHJOURGKXURIW-UHFFFAOYSA-N gamma-cadinene Natural products CC(C)C1CCC(=C2CCC(=C)CC12)C JBHJOURGKXURIW-UHFFFAOYSA-N 0.000 claims description 4
- RVOXATXFYDNXRE-UHFFFAOYSA-N gamma-elemene Natural products CC(=C1CCC(C)(C(C1)C(=C)C)C(=C)C)C RVOXATXFYDNXRE-UHFFFAOYSA-N 0.000 claims description 4
- TWVJWDMOZJXUID-QJPTWQEYSA-N guaiol Natural products OC(C)(C)[C@H]1CC=2[C@H](C)CCC=2[C@@H](C)CC1 TWVJWDMOZJXUID-QJPTWQEYSA-N 0.000 claims description 4
- SVURIXNDRWRAFU-UHFFFAOYSA-N juniperanol Natural products C1C23C(C)CCC3C(C)(C)C1C(O)(C)CC2 SVURIXNDRWRAFU-UHFFFAOYSA-N 0.000 claims description 4
- MXDMETWAEGIFOE-UHFFFAOYSA-N rac-delta-elemene Natural products CC(C)C1=CC(C(C)=C)C(C)(C=C)CC1 MXDMETWAEGIFOE-UHFFFAOYSA-N 0.000 claims description 4
- USDOQCCMRDNVAH-UHFFFAOYSA-N sigma-cadinene Natural products C1C=C(C)CC2C(C(C)C)CC=C(C)C21 USDOQCCMRDNVAH-UHFFFAOYSA-N 0.000 claims description 4
- LHYHMMRYTDARSZ-XQLPTFJDSA-N tau-cadinol Chemical compound C1CC(C)=C[C@H]2[C@H](C(C)C)CC[C@](C)(O)[C@@H]21 LHYHMMRYTDARSZ-XQLPTFJDSA-N 0.000 claims description 4
- AYXPYQRXGNDJFU-IMNVLQEYSA-N viridiflorol Chemical compound [C@@H]1([C@@](CC[C@@H]2[C@H]3C2(C)C)(C)O)[C@H]3[C@H](C)CC1 AYXPYQRXGNDJFU-IMNVLQEYSA-N 0.000 claims description 4
- IHPKGUQCSIINRJ-UHFFFAOYSA-N β-ocimene Natural products CC(C)=CCC=C(C)C=C IHPKGUQCSIINRJ-UHFFFAOYSA-N 0.000 claims description 4
- CSKINCSXMLCMAR-UHFFFAOYSA-N β-patchoulene Chemical compound C1C(C2(C)C)CCC2(C)C2=C1C(C)CC2 CSKINCSXMLCMAR-UHFFFAOYSA-N 0.000 claims description 4
- BXGVVQADPFXGHD-UHFFFAOYSA-N (+)-widdrol Natural products C1CC(C)(O)CC=C2C(C)(C)CCCC21C BXGVVQADPFXGHD-UHFFFAOYSA-N 0.000 claims description 3
- AYXPYQRXGNDJFU-QTPLKFIXSA-N (-)-Globulol Chemical compound [C@H]1([C@](CC[C@@H]2[C@H]3C2(C)C)(C)O)[C@H]3[C@H](C)CC1 AYXPYQRXGNDJFU-QTPLKFIXSA-N 0.000 claims description 3
- AYXPYQRXGNDJFU-QUMMREBQSA-N (-)-Globulol Natural products O[C@@]1(C)[C@H]2[C@H]([C@H](C)CC2)[C@@H]2C(C)(C)[C@@H]2CC1 AYXPYQRXGNDJFU-QUMMREBQSA-N 0.000 claims description 3
- YSTPAHQEHQSRJD-UHFFFAOYSA-N 3-Carvomenthenone Chemical compound CC(C)C1CCC(C)=CC1=O YSTPAHQEHQSRJD-UHFFFAOYSA-N 0.000 claims description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 3
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 claims description 3
- QMAYBMKBYCGXDH-RRFJBIMHSA-N alpha-Muurolene Natural products C1CC(C)=C[C@@H]2[C@H](C(C)C)CC=C(C)[C@H]21 QMAYBMKBYCGXDH-RRFJBIMHSA-N 0.000 claims description 3
- QMAYBMKBYCGXDH-ZNMIVQPWSA-N alpha-muurolene Chemical compound C1CC(C)=C[C@H]2[C@H](C(C)C)CC=C(C)[C@H]21 QMAYBMKBYCGXDH-ZNMIVQPWSA-N 0.000 claims description 3
- IRAQOCYXUMOFCW-CXTNEJHOSA-N cedrene Chemical compound C1[C@]23[C@H](C)CC[C@H]3C(C)(C)[C@H]1C(C)=CC2 IRAQOCYXUMOFCW-CXTNEJHOSA-N 0.000 claims description 3
- KMPWYEUPVWOPIM-UHFFFAOYSA-N cinchonidine Natural products C1=CC=C2C(C(C3N4CCC(C(C4)C=C)C3)O)=CC=NC2=C1 KMPWYEUPVWOPIM-UHFFFAOYSA-N 0.000 claims description 3
- IRAQOCYXUMOFCW-UHFFFAOYSA-N di-epi-alpha-cedrene Natural products C1C23C(C)CCC3C(C)(C)C1C(C)=CC2 IRAQOCYXUMOFCW-UHFFFAOYSA-N 0.000 claims description 3
- 150000002085 enols Chemical class 0.000 claims description 3
- NKIWRYQBASKLRK-UHFFFAOYSA-N globulol Natural products CC1CCC2CC(C)(O)CC3C(C12)C3(C)C NKIWRYQBASKLRK-UHFFFAOYSA-N 0.000 claims description 3
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 claims description 3
- 229930006968 piperitone Natural products 0.000 claims description 3
- 239000011505 plaster Substances 0.000 claims description 3
- WUOACPNHFRMFPN-SECBINFHSA-N (S)-(-)-alpha-terpineol Chemical compound CC1=CC[C@@H](C(C)(C)O)CC1 WUOACPNHFRMFPN-SECBINFHSA-N 0.000 claims description 2
- OVKDFILSBMEKLT-UHFFFAOYSA-N alpha-Terpineol Natural products CC(=C)C1(O)CCC(C)=CC1 OVKDFILSBMEKLT-UHFFFAOYSA-N 0.000 claims description 2
- 229940088601 alpha-terpineol Drugs 0.000 claims description 2
- 239000000022 bacteriostatic agent Substances 0.000 claims description 2
- 239000011297 pine tar Substances 0.000 claims description 2
- 229940068124 pine tar Drugs 0.000 claims description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Natural products CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 2
- 240000007002 Eucalyptus tereticornis Species 0.000 claims 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 229910052938 sodium sulfate Inorganic materials 0.000 claims 1
- 235000011152 sodium sulphate Nutrition 0.000 claims 1
- 239000004615 ingredient Substances 0.000 abstract description 6
- 239000003814 drug Substances 0.000 description 16
- 229940079593 drug Drugs 0.000 description 14
- 210000004027 cell Anatomy 0.000 description 13
- 238000001514 detection method Methods 0.000 description 13
- 239000003921 oil Substances 0.000 description 12
- 235000019198 oils Nutrition 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 239000000047 product Substances 0.000 description 11
- 238000000034 method Methods 0.000 description 10
- 239000012153 distilled water Substances 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- 239000001307 helium Substances 0.000 description 8
- 229910052734 helium Inorganic materials 0.000 description 8
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 239000012159 carrier gas Substances 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 239000001963 growth medium Substances 0.000 description 7
- 230000002401 inhibitory effect Effects 0.000 description 7
- 238000005259 measurement Methods 0.000 description 7
- 239000002994 raw material Substances 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- 241000894007 species Species 0.000 description 7
- 238000010792 warming Methods 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 230000003385 bacteriostatic effect Effects 0.000 description 6
- 230000005764 inhibitory process Effects 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- 229930006722 beta-pinene Natural products 0.000 description 5
- 238000004821 distillation Methods 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 238000011084 recovery Methods 0.000 description 5
- WTARULDDTDQWMU-UHFFFAOYSA-N β-pinene Chemical compound C1C2C(C)(C)C1CCC2=C WTARULDDTDQWMU-UHFFFAOYSA-N 0.000 description 5
- 244000166102 Eucalyptus leucoxylon Species 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 235000008216 herbs Nutrition 0.000 description 4
- 150000002500 ions Chemical class 0.000 description 4
- 230000003902 lesion Effects 0.000 description 4
- 244000025254 Cannabis sativa Species 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000004663 cell proliferation Effects 0.000 description 3
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 3
- 238000004939 coking Methods 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 238000012850 discrimination method Methods 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 230000010355 oscillation Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 2
- 235000005749 Anthriscus sylvestris Nutrition 0.000 description 2
- 240000004467 Cryptotaenia canadensis Species 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 239000012980 RPMI-1640 medium Substances 0.000 description 2
- 235000006085 Vigna mungo var mungo Nutrition 0.000 description 2
- 240000005616 Vigna mungo var. mungo Species 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 235000013527 bean curd Nutrition 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 229960005091 chloramphenicol Drugs 0.000 description 2
- 150000001875 compounds Chemical group 0.000 description 2
- 230000003013 cytotoxicity Effects 0.000 description 2
- 231100000135 cytotoxicity Toxicity 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 229940100692 oral suspension Drugs 0.000 description 2
- 230000036407 pain Effects 0.000 description 2
- 235000019477 peppermint oil Nutrition 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000003908 quality control method Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 230000008542 thermal sensitivity Effects 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241000758795 Aristolochiaceae Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 244000281762 Chenopodium ambrosioides Species 0.000 description 1
- 235000000509 Chenopodium ambrosioides Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 244000301850 Cupressus sempervirens Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 244000288780 Geophila repens Species 0.000 description 1
- 240000002045 Guettarda speciosa Species 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- 101000666657 Homo sapiens Rho-related GTP-binding protein RhoQ Proteins 0.000 description 1
- STECJAGHUSJQJN-GAUPFVANSA-N Hyoscine Natural products C1([C@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-GAUPFVANSA-N 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- STECJAGHUSJQJN-UHFFFAOYSA-N N-Methyl-scopolamin Natural products C1C(C2C3O2)N(C)C3CC1OC(=O)C(CO)C1=CC=CC=C1 STECJAGHUSJQJN-UHFFFAOYSA-N 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 240000003889 Piper guineense Species 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 241001529246 Platymiscium Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 102100038339 Rho-related GTP-binding protein RhoQ Human genes 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000012888 bovine serum Substances 0.000 description 1
- 238000002815 broth microdilution Methods 0.000 description 1
- 239000001772 cananga odorata hook. f. and thomas. oil Substances 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229940097572 chloromycetin Drugs 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000000571 coke Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- XUEHVOLRMXNRKQ-HKGGGCDWSA-N cubebene Chemical compound CC(C)[C@H]([C@@H]12)CC[C@H](C)C32C1C(C)=CC3 XUEHVOLRMXNRKQ-HKGGGCDWSA-N 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000004862 elemi Substances 0.000 description 1
- 125000001033 ether group Chemical group 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 230000000749 insecticidal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 229930015704 phenylpropanoid Natural products 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- STECJAGHUSJQJN-FWXGHANASA-N scopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-FWXGHANASA-N 0.000 description 1
- 229960002646 scopolamine Drugs 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B9/00—Essential oils; Perfumes
- C11B9/02—Recovery or refining of essential oils from raw materials
- C11B9/025—Recovery by solvent extraction
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
- A61K36/264—Aristolochia (Dutchman's pipe)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B9/00—Essential oils; Perfumes
- C11B9/02—Recovery or refining of essential oils from raw materials
- C11B9/022—Refining
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B9/00—Essential oils; Perfumes
- C11B9/02—Recovery or refining of essential oils from raw materials
- C11B9/027—Recovery of volatiles by distillation or stripping
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/37—Extraction at elevated pressure or temperature, e.g. pressurized solvent extraction [PSE], supercritical carbon dioxide extraction or subcritical water extraction
Abstract
The invention discloses a kind of application of ford dutchmanspipe root or herb volatile oil in preparing anti-curing cancers and/antibacterial product.The step of ford dutchmanspipe root or herb volatile oil, extraction is:(1) ford dutchmanspipe root or herb is crushed, adds stirring progress steam distillation extraction after water, obtains water system containing volatile oil;(2) organic solvent is added into water system containing volatile oil to be extracted, discards the water layer separated, dehydration and drying agent dehydration is added into the organic solvent containing volatile oil, organic solvent is recovered by filtration to get to the pure volatile oil of drying.The ingredient of the ford dutchmanspipe root or herb obtained using steam distillation can have good antibacterial and active anticancer simultaneously.
Description
Technical field
The present invention relates to a kind of application of ford dutchmanspipe root or herb volatile oil in preparing anti-curing cancers and/antibacterial product.
Background technology
Volatile oil (volatile oils), also known as essential oil (essential oils) are one kind can volatilize at normal temperatures
, can with steam distillation, with the general name of the immiscible oily liquids of water.Most of volatile oil have aromatic odor.Volatilization
Oil is a kind of important active constituent, clinically in addition to directly applying the mainly crude drug containing volatile oil, can also apply and therefrom refine
Volatile oil, such as eucalyptus oil, peppermint oil.Volatile oil has diverging inducing diaphoresis, resuscitation with aromatics, regulating qi-flowing for relieving pain, dispelling wind and eliminating dampness, promoting blood circulation
In stagnation resolvation, dispelling cold temperature, clearing heat and detoxicating, relieving summer-heat dispel dirty, insecticidal and antibacterial the effects that.But the active constituent of the volatile oil of separate sources is not
Together, there is also larger differences for function, and such as peppermint oil dispelling-wind invigorating stomach, Angelica oil analgesia, radix bupleuri oil is brought down a fever, and American wormseed oil drives intestines
Worm etc..
Ford dutchmanspipe root or herb, belongs to Aristolochiaceae, ford dutchmanspipe root or herb platymiscium, the brave Tongcheng of alias five, centering grass, natural grass, root hyoscine,
The benefits of removing toxicity for detumescence, dispelling wind and eliminating pain, promoting the circulation of qi cough-relieving.It is distributed in Guangxi, Guangdong, Jiangxi, Zhejiang and the Fujian in China.Adaptability Yushan Hill
In paddy underbrush and in the stone gap of mountainous region.
Currently, the research for ford dutchmanspipe root or herb is less, decoction for oral administration is mostly used, or mashes or grinds and dress external application;Also not
About ford dutchmanspipe root or herb volatile oil extracting and the report used.
Invention content
In view of the deficiencies of the prior art, the object of the present invention is to provide a kind of ford dutchmanspipe root or herb volatile oil to prepare anti-curing cancers
With the application in/antibacterial product.
The step of the first aspect of the present invention, provides a kind of ford dutchmanspipe root or herb volatile oil, extraction be:
(1) ford dutchmanspipe root or herb is crushed, adds stirring progress steam distillation extraction after water, obtains water system containing volatile oil;
(2) organic solvent is added into water system containing volatile oil to be extracted, the water layer separated is discarded, to having containing volatile oil
Dehydration and drying agent dehydration is added in solvent, organic solvent is recovered by filtration to get to the pure volatile oil of drying.
Present invention discover that using steam distillation obtain ford dutchmanspipe root or herb ingredient can have simultaneously it is good it is antibacterial and
Active anticancer.
Preferably, in step (1), it is 50~100 mesh that ford dutchmanspipe root or herb, which is crushed to grain size,;It is further preferred that by ford dutchmanspipe root or herb
It is 60 mesh to be crushed to grain size.
Preferably, in step (1), the mass ratio that ford dutchmanspipe root or herb and water are added is 1:2~6, further preferably 1:3.
Preferably, in step (1), steam distillation extraction time is 3~6h.
Preferably, in step (2), the organic solvent is in ethyl acetate, ethyl acrylate, n-hexane or ether
It is one or more of;Still more preferably it is ether.
Preferably, in step (2), the dehydration and drying agent is selected from anhydrous sodium sulfate or dead plaster;It is further excellent
It is selected as anhydrous sodium sulfate.
Preferably, the chemical composition of ford dutchmanspipe root or herb volatile oil of the invention includes:Nopinene, pseudolimonene, limonene, γ-
Terpinene, terpinolene, linalool, alloocimene, trans- -2- menthols, camphor, terpinene-4-alcohol, alpha-terpineol, pepper
Ketone, δ-elemene, the long firpenes of α-, α-cubebene, β-patchoulene, australene, beta-elemene, comes into leaves at Bronyl acetate
Alkene, eneα-cedar, α-gurjunene, β-carypohyllene, β-farnesene, β-chamigrene, bicyclic big Mang bicyclogermacrene, β-Se Lin alkene, α-
Cloth lamb's-quarters alkene, γ-cadinene, δ-cadinene, the peaceful alkene of cubeb oil, 3,7 (11)-celery diene, α-epoxy cedrene, table blue gum
Alcohol, blue gum alkene, viridiflorol, guaiol, τ-cadinol, cedrol, new Andropogon intermedicus alcohol, cubeb oil enol, Wei get
Alcohol, α-cadinol, intermedeol, bisabol, iodothymol -1 (10)-alkene -9- alcohol, β-grapefruit alcohol, sesquialter myrtanol, α-cananga oil
Alkene -14- alcohol.
The second aspect of the present invention provides a kind of above-mentioned ford dutchmanspipe root or herb volatile oil and is preparing anti-curing cancers and/antibacterial product
In application.
In above application, the product includes:Food, drug or health products.
In above application, the bacterium is staphylococcus aureus, hay bacillus, Escherichia coli or Pseudomonas aeruginosa.Ford dutchmanspipe root or herb
Volatile oil has preferable fungistatic effect to staphylococcus aureus, hay bacillus, Escherichia coli and Pseudomonas aeruginosa.
In above application, the cancer is liver cancer or breast cancer.
The third aspect of the present invention, provides a kind of bacteriostatic agent, and active constituent is above-mentioned ford dutchmanspipe root or herb volatile oil.
The fourth aspect of the present invention provides a kind of pharmaceutical composition of anticancer, above-mentioned Tongcheng containing therapeutically effective amount
Brave volatile oil.
Terms used herein " therapeutically effective amount " indicate, treatment, the disease for improving targeting or illness or show can
The amount of therapeutic agent needed for the therapeutic effect of detection.
The pharmaceutical composition of the present invention is effective in comparatively wide dosage range.Actually take pharmaceutical composition of the present invention
For dosage can be determined according to related situation.These situations include:Physical condition, administration route, age, the body of subject
Again, to the individual reaction of drug, the severity etc. of symptom.
Preferably, various pharmaceutical dosage forms can be made in aforementioned pharmaceutical compositions, and corresponding medicine is matched according to different dosage forms
Oral suspension, capsule, emulsus agent is made in acceptable carrier on, is directly absorbed by stomach and is used for antitumaous effect;
Foaming agent, emulsus agent and suspension can be made, directly smear or be sprayed at lesions position, the principle of externally applied drug is to utilize volatilization
The osmosis of oil, by acting on lesion after skin or mucosa absorption, breast cancer is for example treated in externally applied drug.
Beneficial effects of the present invention are:
(1) present invention uses steam distillation and organic extraction techniques extraction purification to obtain ford dutchmanspipe root or herb volatile oil, institute for the first time
It states extraction process and is directed to ford dutchmanspipe root or herb volatile oil component feature, raw material coking can be effectively prevent, heating process is avoided to cause to volatilize
Thermal sensitivity in oil component, easily decompositions, oxidizable component damages avoid causing volatile oil loss of activity and volatilization oil quality reduction,
Improve the recovery rate of volatile oil component (including ingredient type and active component content);And method for extraction and purification is simple for process,
At low cost, distilled water and organic solvent in preparation process can reuse, the volatile oil obtained through preparation process of the present invention
Moisture content is low, and the main active constituent of volatile oil retains more comprehensively.
(2) present invention establishes composition and the quantitative analysis of ford dutchmanspipe root or herb volatile oil for the first time, passes through the spy of ford dutchmanspipe root or herb volatile oil
The difference of other species volatile oil active constituents of point, establishes the quality control detection side of ford dutchmanspipe root or herb Extraction Process of Volatile Oil respectively
The discriminating of method and ford dutchmanspipe root or herb volatile oil and discrimination method in ford dutchmanspipe root or herb.
(3) the ford dutchmanspipe root or herb volatile oil that extraction purification of the present invention obtains, experiment proves that having simultaneously good antibacterial and anti-
Cancer activity, has good bacteriostasis, to HepG2 to staphylococcus aureus, hay bacillus, Escherichia coli and Pseudomonas aeruginosa
(human liver cancer cell) and MCF-7 (human breast cancer cell) have good anticancer cancer resistant effect, are suitble to industrialized production and application.
Specific implementation mode
It is noted that described further below be all exemplary, it is intended to provide further instruction to the application.Unless another
It indicates, all technical and scientific terms used herein has usual with the application person of an ordinary skill in the technical field
The identical meanings of understanding.
It should be noted that term used herein above is merely to describe specific implementation mode, and be not intended to restricted root
According to the illustrative embodiments of the application.As used herein, unless the context clearly indicates otherwise, otherwise singulative
It is also intended to include plural form, additionally, it should be understood that, when in the present specification using term "comprising" and/or " packet
Include " when, indicate existing characteristics, step, operation, device, component and/or combination thereof.
It is less for the research of ford dutchmanspipe root or herb as background technology is introduced, decoction for oral administration is mostly used, or mash or grind
Mill dresses external application;At present also not about ford dutchmanspipe root or herb volatile oil extracting and the report used.Based on this, present applicant proposes one kind
Application of the ford dutchmanspipe root or herb volatile oil in preparing anti-curing cancers and/antibacterial product.
In a kind of embodiment of the application, a kind of ford dutchmanspipe root or herb volatile oil is provided, the step of extraction is:
(1) ford dutchmanspipe root or herb is crushed, adds stirring progress steam distillation extraction after water, obtains water system containing volatile oil;
(2) organic solvent is added into water system containing volatile oil to be extracted, the water layer separated is discarded, to having containing volatile oil
Dehydration and drying agent dehydration is added in solvent, organic solvent is recovered by filtration to get to the pure volatile oil of drying.
Present invention discover that using steam distillation obtain ford dutchmanspipe root or herb ingredient can have simultaneously it is good it is antibacterial and
Active anticancer.
The existing compound structure having found of plant that ford dutchmanspipe root or herb belongs to is mainly lignanoids, Phenylpropanoid Glycosides class, flavonoids, perfume (or spice)
Beans essence class, organic acid, alcohols, hydro carbons, saponins, amino acid and polysaccharide, volatile oil etc., and inventor has found ford dutchmanspipe root or herb volatilization
The characteristics of the characteristics of oil has oneself and classes of compounds (as shown in table 2), inventor's early-stage study ford dutchmanspipe root or herb volatile oil, using more
Kind mode attempts extraction ford dutchmanspipe root or herb volatile oil, and is detected by GC-MS, finds the volatile oil component overwhelming majority contained by ford dutchmanspipe root or herb
Closing object, solubility is extremely low in water, relatively preferably to be extracted by steam distillation, therefore proposes this programme, compares
For other volatile oil extracting modes, volatile oil extracting efficiency and volatile oil type ratio extract higher.
Wherein, during extraction by steam distillation ford dutchmanspipe root or herb volatile oil, raw material coking, inventor are easily led to the problem of
Experiment finds that the grain size of control ford dutchmanspipe root or herb dry powder is a vital factor, grain size is limited in 50 mesh or more, coking is existing
As obviously disappearing, on this basis, inventor further uses the ratio of suitable ford dutchmanspipe root or herb and distilled water, slows down raw material coke
Change problem and assisted extraction.
In specific embodiment, the mass ratio of the herein described ford dutchmanspipe root or herb cleaned after drying and distilled water is 1:2~
6, further preferably 1:3;It is preferably 60 mesh that the ford dutchmanspipe root or herb, which smashes grain size,;Inventor has found in experimental study, smashes
Grain is larger, and water vapour can be made to be flowed out from raw material gap, so that recovery rate reduces, and waste of resource;And it is too small to smash grain size,
Then so that water vapour can not uniformly penetrate raw material, causes steam to be escaped from the raw material washed open, it is not high to also result in recovery rate.
Further, since the extraction process of ford dutchmanspipe root or herb is newly-established, during the application, inventor is with reference to other plant
The extraction process of volatile oil, however it is different, and volatile oil of the present invention is contained more oxidizable ingredient and (is occupied with alkenes
It is more), to avoid heating process from causing thermal sensitivity in volatile oil component, easily decomposing, oxidizable component damages, water of the present invention steams
Steam distillation extraction time is limited in 3~6h;Suitable extraction time can ensure as far as possible by extracting volatile oil in ford dutchmanspipe root or herb
Component, while the wasting of resources caused by also avoiding extraction time long.
The organic solvent is selected from one or more of ethyl acetate, ethyl acrylate, n-hexane, ether, preferably
Ether;Inventor carries out experiment of single factor discovery for steam distillation-organic solvent extractionprocess, and ether is to ford dutchmanspipe root or herb volatile oil
Component extracting best results have better recovery rate compared to other organic solvents.
The dehydration and drying agent is selected from anhydrous sodium sulfate or dead plaster, preferably anhydrous sodium sulfate.
In the preferred embodiment of the application, the method for extraction and purification of ford dutchmanspipe root or herb volatile oil, including:
(1) it is 60 mesh to be smashed after taking fresh ford dutchmanspipe root or herb is clean to dry to grain size, and stirring progress water vapour after distilled water is added
Distillation, distillation extraction time are 5h, obtain water system containing volatile oil;Wherein, the matter for cleaning ford dutchmanspipe root or herb and distilled water after drying
Amount is than being 1:3;
(2) ether is added into water system containing volatile oil to be extracted, discards the water layer separated, it is molten to the ether containing volatile oil
Anhydrous sodium sulfate dehydration is added in liquid, ether is recovered by filtration and obtains dry pure volatile oil.
The main chemical compositions of the ford dutchmanspipe root or herb volatile oil of acquisition include β-chamigrene, β-carypohyllene, α-cloth lamb's-quarters alkene, β-pinane
Alkene, β-Se Lin alkene, limonene, linalool, bicyclogermacrene, longifolene.
More comprehensively, the main chemical compositions of ford dutchmanspipe root or herb volatile oil of the present invention include:Nopinene, pseudolimonene,
Limonene, γ-terpinene, terpinolene, linalool, alloocimene, trans- -2- menthols, camphor, terpinene-4-alcohol, α-pine
Oleyl alcohol, piperitone, Bronyl acetate, δ-elemene, the long firpenes of α-, α-cubebene, β-patchoulene, australene, β-olive
Fragrant alkene, longifolene, eneα-cedar, α-gurjunene, β-carypohyllene, β-farnesene, β-chamigrene, bicyclic big Mang bicyclogermacrene, β-
Plucked instrument woods alkene, α-cloth lamb's-quarters alkene, γ-cadinene, δ-cadinene, the peaceful alkene of cubeb oil, 3,7 (11)-celery diene, α-epoxy cypress
Alkene, table globulol, blue gum alkene, viridiflorol, guaiol, τ-cadinol, cedrol, new Andropogon intermedicus alcohol, cubeb oil
Enol, widdrol, α-cadinol, intermedeol, bisabol, iodothymol -1 (10)-alkene -9- alcohol, β-grapefruit alcohol, sesquialter Benny
Alcohol, α-muurolene -14- alcohol.
Process quality control, currently preferred reality are carried out for the ease of the more efficiently quality to ford dutchmanspipe root or herb volatile oil
The mode of applying is a kind of detection method by above-mentioned ford dutchmanspipe root or herb volatile oil, and the method includes using gas chromatography-mass spectrography (GC-
MS) analysis detection, the condition of detection are:HP-5MS chromatographic columns (30m × 0.25mm × 0.25 μm);Carrier gas:Helium;Flow velocity:
1.2mL/min, solvent delay 5min;Temperature program:Initial temperature is 60 DEG C, keeps 1min, 200 DEG C are warming up to 6 DEG C/min,
Keep 5min;280 DEG C are warming up to 5 DEG C/min, keeps 2min.Ionization mode:EI, 70eV;Ion source temperature:250℃;It carries
Gas:Helium;Column flow rate:1.2mL/min;
Detect and control the ford dutchmanspipe root or herb chemical composition of volatile oil, including β-chamigrene, β-carypohyllene, α-cloth lamb's-quarters alkene, β-
The control of the ingredients such as firpene, β-Se Lin alkene, limonene, linalool, bicyclogermacrene, longifolene;
More comprehensively, the main chemical compositions for detecting the ford dutchmanspipe root or herb volatile oil include:Nopinene, pseudolimonene, lemon
Lemon alkene, γ-terpinene, terpinolene, linalool, alloocimene, trans- -2- menthols, camphor, terpinene-4-alcohol, α-pine tar
Alcohol, piperitone, Bronyl acetate, δ-elemene, the long firpenes of α-, α-cubebene, β-patchoulene, australene, β-elemi
Alkene, longifolene, eneα-cedar, α-gurjunene, β-carypohyllene, β-farnesene, β-chamigrene, bicyclic big Mang bicyclogermacrene, β-plucked instrument
Woods alkene, α-cloth lamb's-quarters alkene, γ-cadinene, δ-cadinene, the peaceful alkene of cubeb oil, 3,7 (11)-celery diene, α-epoxy cedrene,
Table globulol, blue gum alkene, viridiflorol, guaiol, τ-cadinol, cedrol, new Andropogon intermedicus alcohol, cubebene
Alcohol, widdrol, α-cadinol, intermedeol, bisabol, iodothymol -1 (10)-alkene -9- alcohol, β-grapefruit alcohol, sesquialter myrtanol,
α-muurolene -14- alcohol.
Above-mentioned detection method is used for the discriminating of ford dutchmanspipe root or herb volatile oil in the embodiment of the application.
For example, a kind of discrimination method of ford dutchmanspipe root or herb volatile oil, the method includes volatile oil to be measured is used gas-chromatography-
Mass spectrography (GC-MS) analysis detection, the condition of detection are:HP-5MS chromatographic columns (30m × 0.25mm × 0.25 μm);Carrier gas:Helium
Gas;Flow velocity:1.2mL/min, solvent delay 5min;Temperature program:Initial temperature is 60 DEG C, keeps 1min, is heated up with 6 DEG C/min
To 200 DEG C, 5min is kept;280 DEG C are warming up to 5 DEG C/min, keeps 2min.Ionization mode:EI, 70eV;Ion source temperature:
250℃;Carrier gas:Helium;Column flow rate:1.2mL/min;
Volatile oil testing result to be measured and ford dutchmanspipe root or herb chemical composition of volatile oil (β-chamigrene, β-carypohyllene, α-cloth lamb's-quarters alkene,
Nopinene, β-Se Lin alkene, limonene, linalool, bicyclogermacrene, longifolene) it compares.
A kind of discrimination method of ford dutchmanspipe root or herb, the method includes the extractions of species volatile oil to be measured and species volatile oil to be measured
Detection,
The extraction of the species volatile oil to be measured includes:(1) take species to be measured clean dry after smash to grain size be 50~
100 mesh are added stirring progress steam distillation after distilled water, obtain water system containing volatile oil;
(2) organic solvent is added into water system containing volatile oil to be extracted, the water layer separated is discarded, to having containing volatile oil
Dehydration and drying agent dehydration is added in solvent, organic solvent is recovered by filtration and obtains dry pure volatile oil;
The detection of species volatile oil to be measured includes:By species volatile oil to be measured using gas chromatography-mass spectrography (GC-MS) point
Analysis detection, the condition of detection are:HP-5MS chromatographic columns (30m × 0.25mm × 0.25 μm);Carrier gas:Helium;Flow velocity:1.2mL/
Min, solvent delay 5min;Temperature program:Initial temperature is 60 DEG C, keeps 1min, is warming up to 200 DEG C with 6 DEG C/min, keeps
5min;280 DEG C are warming up to 5 DEG C/min, keeps 2min.Ionization mode:EI, 70eV;Ion source temperature:250℃;Carrier gas:
Helium;Column flow rate:1.2mL/min;
Volatile oil testing result to be measured and ford dutchmanspipe root or herb chemical composition of volatile oil (β-chamigrene, β-carypohyllene, α-cloth lamb's-quarters alkene,
Nopinene, β-Se Lin alkene, limonene, linalool, bicyclogermacrene, longifolene) it compares.
In addition, the present invention has studied the possible function of series of the ford dutchmanspipe root or herb volatile oil, above-mentioned ford dutchmanspipe root or herb volatilization is disclosed
The application of oil.
Inventor also studies the function of excessive ESSENTIAL OIL early period, such as carves dish volatile oil, bean curd dish volatile oil, seta
Wild chervil volatile oil, Geophila herbacea (L) O Kumtze volatile oil etc., but different phytovolatilization oil component is sufficiently complex, and source is different, function there is also
Larger difference understands according to inventor, while having antibacterial, antitumor activity multifunctional usage volatile oil type still less,
Function is still mainly related with active constituent and its related ratio, and inventor is found that bean curd dish volatile oil has the function of this early period,
Seta wild chervil volatile oil also has effects that this, and during research ford dutchmanspipe root or herb volatile oil is crossed, inventor has found that the volatile oil is same
When there are good antibacterial and active anticancer multiple functions, to staphylococcus aureus, hay bacillus, Escherichia coli and green pus bar
Bacterium has good bacteriostasis, presses down with good anticancer to HepG2 (human liver cancer cell) and MCF-7 (human breast cancer cell)
Cancer effect.
In the other embodiment of the application, discloses a kind of above-mentioned ford dutchmanspipe root or herb volatile oil and preparing anti-curing cancers
With the application in/antibacterial product.
Further, the product includes:Food, drug or health products.The bacterium is staphylococcus aureus, withered grass bar
Bacterium, Escherichia coli or Pseudomonas aeruginosa.Ford dutchmanspipe root or herb volatile oil is to staphylococcus aureus, hay bacillus, Escherichia coli and green pus bar
Bacterium has preferable fungistatic effect.The cancer is liver cancer or breast cancer.
Such as drug, it is corresponding pharmaceutically acceptable according to different dosage form apolegamys using ford dutchmanspipe root or herb volatile oil as raw material
Oral suspension, capsule, emulsus agent is made in carrier, is directly absorbed by stomach and is used for antitumaous effect;Foam can be made
Agent, emulsus agent and suspension, directly smear or are sprayed at lesions position, and the principle of externally applied drug is made using the infiltration of volatile oil
With by acting on lesion after skin or mucosa absorption, breast cancer is for example treated in externally applied drug.
In order to enable those skilled in the art can clearly understand the technical solution of the application, below with reference to tool
The technical solution of the application is described in detail in the embodiment of body.
Test material used in following embodiment is the test material of this field routine, can be purchased by commercial channel
It can buy.
Embodiment 1:Preliminary experiment
Different extracting methods is respectively adopted to extract ford dutchmanspipe root or herb volatile oil, it is specific as follows:
1. steam distillation:
(1) it takes the dry ford dutchmanspipe root or herbs of 500g to smash, stirring progress steam distillation after 1500g distilled water is added, when distilling extraction
Between be 5h, obtain water system containing volatile oil;
(2) ether is added into water system containing volatile oil to be extracted, discards the water layer separated, it is molten to the ether containing volatile oil
Anhydrous sodium sulfate dehydration is added in liquid, ether is recovered by filtration and obtains dry pure volatile oil.
2. Simultaneous distillation:
It weighs the dry ford dutchmanspipe root or herbs of 500g to smash in distilling flask towel, 1500g aquae destillatas is added, while measuring ether and being burnt in distillation
In bottle, moral extraction equipment is connected while being steamed, while steaming and extraction is stayed to collect ether solution, anhydrous sodium sulfate is used in combination to be dehydrated, ether extraction
Liquid is concentrated in rotavapor under vacuum, obtains volatile oil.
3. aether backflow extraction:
It weighs the dry ford dutchmanspipe root or herbs of 500g to smash in distilling flask towel, ether is added and carries out reflux extraction.
The investigation of preliminary experiment the results are shown in Table 1.
1 preliminary result of table
As can be seen from Table 1, higher using the volatile oil yield of steam distillation, therefore, for waving in subsequent experimental
The extraction of hair oil uses steam distillation.
Embodiment 2:The method for extraction and purification of ford dutchmanspipe root or herb volatile oil
(1) take the fresh ford dutchmanspipe root or herbs of 500g clean dry after smash to grain size be 60 mesh, be added 1500g distilled water after stir into
Row steam distillation, distillation extraction time are 5h, obtain water system containing volatile oil;
(2) ether is added into water system containing volatile oil to be extracted, discards the water layer separated, it is molten to the ether containing volatile oil
Anhydrous sodium sulfate dehydration is added in liquid, ether is recovered by filtration and obtains dry pure volatile oil;Recovery rate is 0.32%, volatilization
Moisture content in oil is 0.55%.
Embodiment 3:The detection method of ford dutchmanspipe root or herb volatile oil
The ford dutchmanspipe root or herb volatile oil that embodiment 2 obtains is detected using GC-MS, the condition specifically detected is as follows:HP-
5MS chromatographic columns (30m × 0.25mm × 0.25 μm);Carrier gas:Helium;Flow velocity:1.2mL/min, solvent delay 5min;Heat up journey
Sequence:Initial temperature is 60 DEG C, keeps 1min, is warming up to 200 DEG C with 6 DEG C/min, keeps 5min;It is warming up to 280 with 5 DEG C/min
DEG C, keep 2min.Ionization mode:EI, 70eV;Ion source temperature:250℃;Carrier gas:Helium;Column flow rate:1.2mL/min.Altogether
Detect that 51 kinds of chemical composition in ford dutchmanspipe root or herb volatile oil, specific chemical composition and relative amount are shown in Table 2.
2 ford dutchmanspipe root or herb chemical composition of volatile oil of table
Embodiment 4:The bacteriostasis of ford dutchmanspipe root or herb volatile oil
1. testing strain and culture medium
Test strain:Four kinds of bacterium bacterial strains of selection are used for bacteriostatic test, including gram-positive bacteria:Staphylococcus aureus
(ATCC 6538), bacillus subtilis (ATCC 6633) and Gram-negative bacteria:Escherichia coli (ATCC 25922), green pus bar
Bacterium (ATCC 27853).
Experiment culture medium:Bacterium MHB (Mueller Hinton Broth) culture medium.
2. test method
(1) it sterilizes:
It is damp and hot at 121 DEG C that required culture medium, test tube, culture dish, filter paper (6mm), pipette tips, distilled water etc. will be tested
Sterilize 20min, and bacterium of having gone out is placed superclean bench ultraviolet sterilization 30min.
(2) preparation of bacteria suspension:
It is inoculated in corresponding MHB culture mediums from one ring thalline of picking on the thalline inclined-plane through overactivation, is put into constant temperature and shakes
Culture overnight under the conditions of 37 DEG C in bed.Draw respectively it is above it is cultured in exponential phase for trying bacterium solution 0.5mL, use MH
Bacteria suspension of the broth dilution at 0.5 Maxwell than turbid standard.After above-mentioned bacteria suspension is carried out 1: 100 dilution with MH meat soups again, 1 is obtained
~2 × 106CFU/ml is spare.
(3) for reagent object:
Control drug:Chloramphenicol;Sample:The 5mg/mL dilutions of 2 gained ford dutchmanspipe root or herb volatile oil of embodiment.
(4) measurement of bacteriostatic activity:
Bacteriostatic activity is measured using filter paper enzyme.Under aseptic condition, MHA culture mediums are poured into sterilized culture dish
Solid plate is made after cooled and solidified in 20mL.The bacteria suspension that 100 μ L have diluted is added into each solid plate, coating is equal
It is even, 5min is placed, culture medium is made to fully absorb bacterium solution.With marking pen on having bacterio-agar tablet label.It will be gone out with aseptic nipper
The filter paper of the drying of complete bacterium presss from both sides out, is put into the culture dish for writing corresponding control number, is dripped to the filter paper of sterilized drying
Add 10 μ L of prepared sample solution or chloromycetin solution, each sample do three it is parallel, be put into 37 DEG C of constant incubator cultures
25h.Incubation time takes out culture dish after arriving and observes transparent inhibition zone, and each inhibition zone is measured using crossing method micrometer
The diameter of two vertical direction, it is measurement result to take its average value (mm), each bacteriostatic experiment is parallel to be repeated 3 times.With
The size of antibacterial circle diameter carries out the judgement of bacteriostatic activity power, and inhibition zone shows bigger, then show its antibacterial activity
It is stronger.
(5) measurement of MIC:
It draws the bacterium solution diluted to be added in 96 porocyte culture plates, per 100 μ L of hole, and it is dense that configured good difference is added
The 100 μ L of drug of degree.Hole second from the bottom is not added with drug (only plus culture medium and bacterium) and dilution 100 μ L of bacterium solution is added, and is given birth to for bacterium
Long control wells.Last is classified as positive control chloramphenicol.It is placed on oscillator and vibrates 1min, make after solution mixes well in hole,
The oscillation of 96 orifice plates is shaken up after being placed on and being cultivated 16~18 hours in 37 DEG C of constant incubators, into every hole, addition sterile water is matched
The 20 μ L of 1%TTC (2,3, 5-Triphenyltertrazoliumchloride) solution set, oscillation shake up in 37 DEG C of constant incubators culture 30~
It 60 minutes, observes per hole color change.It takes and volatile oil contained by last hole of color change is not presented a concentration of its is minimum antibacterial
Concentration MIC.
The measurement for repeating all MIC values is triplicate.
3. experimental result
Fungistatic effect indicates that measurement result is shown in Table 3 with minimal inhibitory concentration MIC.
3 ford dutchmanspipe root or herb volatile oil bacteriostatic activity of table
As can be seen from Table 3,4 kinds of ford dutchmanspipe root or herb volatile oil pair has certain inhibiting effect for examination bacterium, to golden yellow Portugal
The minimum inhibitory concentration of grape coccus is 0.078mg/mL, and the minimum inhibitory concentration to hay bacillus is 0.078mg/mL, to large intestine
The minimum inhibitory concentration of bacillus is more than 5.00mg/mL, and the minimum inhibitory concentration to Pseudomonas aeruginosa is 2.50mg/mL.
By be embodied example illustrate ford dutchmanspipe root or herb volatile oil can be used as natural antibacterial agent for food, drugs and health care products or
Cosmetic industry, instead of the synthetic antibacterial agents of toxic side effect.
Embodiment 5:The cytotoxicity of ford dutchmanspipe root or herb volatile oil
1. cell culture
HepG2 (human liver cancer cell) and MCF-7 (human breast cancer cell) cell strain, which are used, contains 10% newborn bovine serum and blueness
The RPMI1640 culture mediums of each 100U/mL of mycin, streptomysin be placed in 37 DEG C, saturated humidity, 5%CO2Incubator in cultivate.
2.MTT methods detect cell viability
The tumour cell of logarithmic growth phase is suspended in the RPMI-1640 containing 10% fetal calf serum and 2mM glutamine
In culture medium, single cell suspension is gently blown and beaten into glass pipette, is counted with TC10 automated cell calculating instruments.By cell inoculation in
96 well culture plates, cell density are 5 × 103A/mL, per 200 μ L of hole.In 37 DEG C, 5%CO2Incubator preculture 25h make carefully
After born of the same parents' adherency, it is respectively 0.016,0.031,0.063,0.125,0.250,0.500,1 and 2mg/ that the concentration prepared in advance, which is added,
The volatile oil of mL (is prepared) solution by embodiment 2 and handled tumour cell.And set negative control and blank control.Distinguish again
Continuous culture 25h, 48h, 72h, are then measured with mtt assay.The MTT solution of 10 μ L 5mg/mL is added per hole, continues to cultivate 2h
Afterwards, supernatant is sucked.100 μ L DMSO are added per hole, setting micro oscillator oscillation 10min makes crystallization be completely dissolved, in
Multiskan Ascent microplate reader measures absorbance (A) value at wavelength 570nm, calculates cell proliferation inhibition rate, the measurement
In triplicate.Cell proliferation inhibition rate calculates as follows.
Cell proliferation inhibition rate/%=[1-ODProcessing group/ODControl]× 100%
3. experimental result
Required sample concentration i.e. (IC when cytotoxicity is to inhibit 50% cell growth50Value) it indicates, measurement result is shown in Table 4.
4 ford dutchmanspipe root or herb volatile oil of table is to HepG2, MCF-7 cytotoxic activity
As can be seen from Table 4, ford dutchmanspipe root or herb volatile oil has certain inhibiting effect to two kinds of cells of HepG2, MCF-7,
To 72 hours IC of HepG250For 0.69mg/mL;To 72 hours IC of MCF-750For 0.22mg/mL.
The above results illustrate that ford dutchmanspipe root or herb volatile oil can be used as natural anti-cancer cell agent for food, drug or health care conduct
Industry.
The foregoing is merely the preferred embodiments of the application, are not intended to limit this application, for the skill of this field
For art personnel, the application can have various modifications and variations.Within the spirit and principles of this application, any made by repair
Change, equivalent replacement, improvement etc., should be included within the protection domain of the application.
Claims (10)
1. a kind of ford dutchmanspipe root or herb volatile oil, characterized in that the step of extraction is:
(1) ford dutchmanspipe root or herb is crushed, adds stirring progress steam distillation extraction after water, obtains water system containing volatile oil;
(2) organic solvent is added into water system containing volatile oil to be extracted, the water layer separated is discarded, to organic molten containing volatile oil
Dehydration and drying agent dehydration is added in agent, organic solvent is recovered by filtration to get to the pure volatile oil of drying.
2. ford dutchmanspipe root or herb volatile oil as described in claim 1, characterized in that in step (1), it is 50 that ford dutchmanspipe root or herb, which is crushed to grain size,
~100 mesh;It is further preferred that it is 60 mesh that ford dutchmanspipe root or herb, which is crushed to grain size,;
Or, in step (1), the mass ratio that ford dutchmanspipe root or herb and water are added is 1:2~6, further preferably 1:3.
3. ford dutchmanspipe root or herb volatile oil as described in claim 1, characterized in that in step (1), steam distillation extraction time is 3
~6h.
4. ford dutchmanspipe root or herb volatile oil as described in claim 1, characterized in that in step (2), the organic solvent is selected from acetic acid second
One or more of ester, ethyl acrylate, n-hexane or ether;Further preferably ether.
5. ford dutchmanspipe root or herb volatile oil as described in claim 1, characterized in that in step (2), the dehydration and drying agent is selected from anhydrous
Sodium sulphate or dead plaster;Still more preferably it is anhydrous sodium sulfate.
6. ford dutchmanspipe root or herb volatile oil as described in claim 1, characterized in that the chemical composition of ford dutchmanspipe root or herb volatile oil includes:β-pinane
Alkene, pseudolimonene, limonene, γ-terpinene, terpinolene, linalool, alloocimene, trans- -2- menthols, camphor, pine tar
Alkene -4- alcohol, alpha-terpineol, piperitone, Bronyl acetate, δ-elemene, the long firpenes of α -, α-cubebene, β-patchoulene,
It is australene, beta-elemene, longifolene, eneα-cedar, α-gurjunene, β-carypohyllene, β-farnesene, β-chamigrene, bicyclic big
Mang bicyclogermacrene, β-Se Lin alkene, α-cloth lamb's-quarters alkene, γ-cadinene, δ-cadinene, the peaceful alkene of cubeb oil, 3,7 (11)-celery diene,
α-epoxy cedrene, table globulol, blue gum alkene, viridiflorol, guaiol, τ-cadinol, cedrol, new Andropogon intermedicus
Alcohol, cubeb oil enol, widdrol, α-cadinol, intermedeol, bisabol, iodothymol -1 (10)-alkene -9- alcohol, β-grapefruit
Alcohol, sesquialter myrtanol, α-muurolene -14- alcohol.
7. a kind of claim 1~6 any ford dutchmanspipe root or herb volatile oil is preparing anti-curing cancers and answering in/antibacterial product
With.
8. the use as claimed in claim 7, characterized in that the bacterium is staphylococcus aureus, hay bacillus, Escherichia coli
Or Pseudomonas aeruginosa.Ford dutchmanspipe root or herb volatile oil has staphylococcus aureus, hay bacillus, Escherichia coli and Pseudomonas aeruginosa preferable
Fungistatic effect;
Or, the cancer is liver cancer or breast cancer.
9. a kind of bacteriostatic agent, characterized in that active constituent is any ford dutchmanspipe root or herb volatile oil of claim 1~6.
10. a kind of pharmaceutical composition of anticancer, characterized in that it is any described that it contains the claim 1~6 of therapeutically effective amount
Ford dutchmanspipe root or herb volatile oil.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810449997.7A CN108690724A (en) | 2018-05-11 | 2018-05-11 | A kind of application of ford dutchmanspipe root or herb volatile oil in preparing anti-curing cancers and/antibacterial product |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810449997.7A CN108690724A (en) | 2018-05-11 | 2018-05-11 | A kind of application of ford dutchmanspipe root or herb volatile oil in preparing anti-curing cancers and/antibacterial product |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108690724A true CN108690724A (en) | 2018-10-23 |
Family
ID=63847335
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810449997.7A Pending CN108690724A (en) | 2018-05-11 | 2018-05-11 | A kind of application of ford dutchmanspipe root or herb volatile oil in preparing anti-curing cancers and/antibacterial product |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108690724A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110227071A (en) * | 2019-08-05 | 2019-09-13 | 江西省林业科学院 | Compound borneol antibacterial agent |
CN113021558A (en) * | 2021-03-17 | 2021-06-25 | 浙江省林业科学研究院 | Preparation method of wear-resistant antibacterial bamboo straw |
CN113025418A (en) * | 2021-03-16 | 2021-06-25 | 山东智汇达海洋生物科技有限公司 | Preparation and application of volatile oil of Odontia papyrifera |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107014933A (en) * | 2017-04-13 | 2017-08-04 | 山东大学 | A kind of extraction purification of seta wild chervil volatile oil and detection method and its application |
-
2018
- 2018-05-11 CN CN201810449997.7A patent/CN108690724A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107014933A (en) * | 2017-04-13 | 2017-08-04 | 山东大学 | A kind of extraction purification of seta wild chervil volatile oil and detection method and its application |
Non-Patent Citations (2)
Title |
---|
冀晓雯,等: "通城虎不同部位挥发油成分的GC-MS分析", 《中药材》 * |
姜冬梅,等: "芳樟醇药理作用及制剂研究进展", 《中国中药杂志》 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110227071A (en) * | 2019-08-05 | 2019-09-13 | 江西省林业科学院 | Compound borneol antibacterial agent |
CN110227071B (en) * | 2019-08-05 | 2019-11-22 | 江西省林业科学院 | Compound borneol antibacterial agent |
CN113025418A (en) * | 2021-03-16 | 2021-06-25 | 山东智汇达海洋生物科技有限公司 | Preparation and application of volatile oil of Odontia papyrifera |
CN113025418B (en) * | 2021-03-16 | 2022-12-06 | 山东智汇达海洋生物科技有限公司 | Preparation and application of volatile oil of Odontia papyrifera |
CN113021558A (en) * | 2021-03-17 | 2021-06-25 | 浙江省林业科学研究院 | Preparation method of wear-resistant antibacterial bamboo straw |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103127215B (en) | Extract of joss-stick having anti-arthritic activity | |
CN102283866A (en) | Method for extracting propolis containing high-purity flavones | |
Alamgir et al. | Herbal drugs: their collection, preservation, and preparation; evaluation, quality control, and standardization of herbal drugs | |
CN105193876B (en) | Purslane extract and preparation method thereof | |
CN108690724A (en) | A kind of application of ford dutchmanspipe root or herb volatile oil in preparing anti-curing cancers and/antibacterial product | |
CN101138432A (en) | Cigarette containing Chinese medicinal herb additive agent and method of producing the same | |
Khan et al. | Evaluation of antioxidant and antimicrobial activities of Bergenia ciliata Sternb (Rhizome) crude extract and fractions. | |
CN113440563B (en) | Compound houttuynia cordata spray and preparation method and application thereof | |
CN106511512A (en) | Traditional Chinese medicine external-use gel and preparation method and application thereof | |
CN107014933A (en) | A kind of extraction purification of seta wild chervil volatile oil and detection method and its application | |
CN104224813B (en) | Pharmaceutical composition as well as preparation method and application thereof | |
CN108926584A (en) | The antimicrobial purposes of chimonanthea extract | |
CN107164096A (en) | A kind of extraction purification of Geophila herbacea (L) O Kumtze volatile oil and detection method and its application | |
CN109181852A (en) | A kind of Herba Malvastri Coromandeliani volatile oil is preparing the application in anti-curing cancers and antibacterial product | |
CN106867674B (en) | Extraction, purification and detection method of bean curd vegetable volatile oil and application thereof | |
CN104491121B (en) | It is a kind of to be used to treat antibacterial Essence of breathing problem and preparation method thereof | |
JP2016128434A (en) | Production method of natural benzaldehyde water, natural benzaldehyde water produced by production method, and antitumor agent containing natural benzaldehyde water | |
CN108395927A (en) | A kind of scotch bonnet bacterium oil and preparation method | |
CN108653454A (en) | Purposes of the Chinese medicine composition of the black pearl containing thorn in treating porcine contagious pleuropneumonia | |
CN105311131B (en) | A kind of Chinese medicine composition and its preparation method and application with antibacterial anti-inflammatory | |
Mangali | Antimicrobial activity of Orthosiphon aristatus (Balbas Pusa) nano particle and leaf extract against E. coli and S. aureus | |
CN106833904A (en) | A kind of extraction purification for carving dish volatile oil and detection method and its application | |
Dixit et al. | Evaluation of phytochemical and antimicrobial activity of Ocimum spp | |
Jagtap et al. | FORMULATION AND DEVELOPMENT OF ANTI-ACNE SERUM USING EUPHORBIA HIRTA. | |
CN100551417C (en) | A kind of food antibiotic and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20181023 |